RBC Capital Remains a Hold on Design Therapeutics (DSGN)
RBC Capital analyst Leonid Timashev maintained a Hold rating on Design Therapeutics (DSGN – Research Report) yesterday and set a price ...
Business Insider20h
RBC Capital Remains a Hold on Mueller Water Products (MWA)
In a report released yesterday, Deane Dray from RBC Capital maintained a Hold rating on Mueller Water Products (MWA – Research Report), with a price target of $25.00. The company’s shares closed ...